Stay True to Our Original Aspiration, Forge Ahead into the Future｜Alphamab Oncology 2025 R&D Day Successfully Held
SUZHOU, China, Dec. 10, 2025 /PRNewswire/ -- On December 8, 2025, Alphamab Oncology (Stock Code: 9966.HK) successfully held its "Stay True to Our Original Aspiration, Forge Ahead into the Future" 2025 R&D Day in Shanghai. The event focused on the latest advancements in the field of antibody-drug conjugates (ADCs), comprehensively showcasing the company's R&D achievements in bispecific ADCs and dual-payload...
Stay True to Our Original Aspiration, Forge Ahead into the Future｜Alphamab Oncology 2025 R&D Day Successfully Held
SUZHOU, China, Dec. 10, 2025 /PRNewswire/ -- On December 8, 2025, Alphamab Oncology (Stock Code: 9966.HK) successfully held its "Stay True to Our Original Aspiration, Forge Ahead into the Future" 2025 R&D Day in Shanghai. The event focused on the latest advancements in the field of antibody-drug conjugates (ADCs), comprehensively showcasing the company's R&D achievements in bispecific ADCs and dual-payload...
DKSH Healthcare Launches Three-Part Whitepaper Series Showcasing Asia Pacific’s Growing Healthcare Outsourcing Opportunity
DKSH Business Unit Healthcare Launches a three-part whitepaper series to help healthcare and life science companies explore industry trends and current market pressures to re-think commercial go-to market approaches in the Asia Pacific region. The whitepaper series demonstrates how strategic Commercial Outsourcing partnerships are evolving to deliver sustainable growth, resource agility, and...
BIG CARiNG Group Partners with Lark to Drive Digital Healthcare Transformation, Enhancing Efficiency and Customer Experience
KUALA LUMPUR, Malaysia, Dec. 10, 2025 /PRNewswire/ -- Lark, the all-in-one productivity platform trusted by leading brands across Southeast Asia, is proud to partner with BIG CARiNG Group to implement and deploy Lark's productivity tools across BIG CARiNG Group's operating network of over 600 community stores nationwide. Through this partnership, Lark will serve as the central platform connecting headquarters,...
Empowering Modern Mothers: Ddrops® Supports the Health of Children and Families
KUALA LUMPUR, Malaysia, Dec. 10, 2025 /PRNewswire/ -- Ddrops® participated in the Dear Mom x Ddrops® event, hosted by Innity Group, at IPC Shopping Centre, Malaysia, to engage with modern mothers and emphasize the importance of maternal support, emotional well-being, and self-care. Reflecting the realities of motherhood today, the event featured interactive zones, including the Self-Love Consultation Booth, Sponsored...
MALAYSIA UNVEILS FIRST FLAGSHIP MEDICAL TOURISM HOSPITAL AWARD WINNER TO DRIVE GLOBAL ECONOMY COMPETITIVENESS
KUALA LUMPUR, Malaysia, Dec. 10, 2025 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC) marked a major milestone in its medical tourism journey today with the announcement of the Winner of the Flagship Medical Tourism Hospital (FMTH) Programme, an initiative initiated and led by the Malaysia Healthcare Travel Council (MHTC) to elevate Malaysia's position as...
D3 Bio Secures $108 Million in Series B Financing to Advance Global Clinical Programs
SHANGHAI, Dec. 10, 2025 /PRNewswire/ -- D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, announced the completion of a $108 million Series B financing round. The funding round was backed by a distinguished group of investors, including IDG Capital and SongQing Capital....
Innovent Announces First Participant Dosed in a Phase 1 Clinical Trial of IBI3011, a Recombinant Anti-Human Interleukin 1 Receptor Accessory Protein Monoclonal Antibody
SAN FRANCISCO and SUZHOU, China, Dec. 10, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major disease areas, announced that the first participant has been successfully dosed in a Phase 1 clinical trial of IBI3011, an anti-human...
PhyxUp Health Leads Innovation in US Rehabilitation Market with AI-Powered Remote Therapeutic Monitoring(RTM), Launches $1M Seed Funding Round
SAN FRANCISCO, Dec. 10, 2025 /PRNewswire/ -- PhyxUp Health, an AI-driven Remote Therapeutic Monitoring (RTM) platform founded by a former physical therapist and Harvard graduate, is transforming how rehabilitation clinics operate throughout the United States. Built as a next-generation patient management and engagement solution, PhyxUp enables clinics to remotely monitor patient progress, increase therapy adherence, and streamline communication beyond the...
BestQool Launches Christmas Campaign Crossing Into 2026 Before the Next Wave of New Product Updates
NEW YORK, Dec. 9, 2025 /PRNewswire/ -- BestQool is now giving a holiday offer to help people smoothly move into 2026 as the year comes to an end and the holidays approach. From December 10, 2025, to January 4, 2026, customers can get 15% off all BestQool light therapy products on the BestQool official website. Also, from December 24,...
